Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xionglong analgesic nasal spray
- Development stage
- Unknown
- Lead developer
- Beijing Yikangtai Technology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Intranasal
01
Overview
Xionglong analgesic nasal spray is a Traditional Chinese Medicine (TCM) formulation developed by Beijing Yikangtai Technology for the acute treatment of migraine. The product is specifically indicated for patients exhibiting the "blood stasis blocking collaterals" pattern, a diagnostic category in TCM characterized by impaired microcirculation and localized pain. The formulation is derived from extracts of *Ligusticum chuanxiong* (Chuanxiong) and *Pheretima* (Dilong/earthworm), which are traditionally used to promote blood circulation, resolve stasis, and alleviate pain. Administered intranasally, the spray is designed to provide rapid absorption and bypass first-pass metabolism, offering a faster onset of action for migraine relief compared to oral alternatives.
- Other names
- 芎龙止痛鼻喷雾剂Xionglong Zhitong Bipunjuji
Beyond the preview
Go deeper on Xionglong analgesic nasal spray.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xionglong analgesic nasal spray.